Skip to main content

Despite Its First TRT Trial Win, Auxilium Opts To Settle

Despite Its First TRT Trial Win, Auxilium Opts To Settle

Despite Its First TRT Trial Win, Auxilium Opts To Settle

Introduction

Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the plaintiff who suffered a stroke (induced by Testim gel use) included marketing an unreasonably dangerous product and misleading the consumers by false marketing gimmicks which characterized low testosterone levels normally experienced by ageing men as an “epidemic” and a “syndrome” called “Low-T”.

Over 6,000 testosterone replacement therapy (TRT) lawsuits have been centralized under MDL No. 2545 in the U.S. District Court for the Northern District of Illinois before U.S. District Judge Matthew Kennelly. Three bellwethers convened last year resulted in two wins for the plaintiffs totalling about $290 million to be paid by AndroGel maker AbbVie and one win for Auxilium.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.